Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081215975> ?p ?o ?g. }
- W3081215975 endingPage "792" @default.
- W3081215975 startingPage "792" @default.
- W3081215975 abstract "A cyclic peptide containing one cysteine and five alternating tryptophan and arginine amino acids [(WR)5C] was synthesized using Fmoc/tBu solid-phase methodology. The ability of the synthesized cyclic peptide to produce gadolinium nanoparticles through an in situ one-pot mixing of an aqueous solution of GdCl3 with [(WR)5C] peptide solution was evaluated. Transmission electron microscopy showed the formed peptide-Gd nanoparticles in star-shape morphology with a size of ~250 nm. Flow cytometry investigation showed that the cellular uptake of a cell-impermeable fluorescence-labeled phosphopeptide (F′-GpYEEI, where F′ = fluorescein) was approximately six times higher in the presence of [(WR)5C]-Gd nanoparticles than those of F′-GpYEEI alone in human leukemia adenocarcinoma (CCRF-CEM) cells after 2 h incubation. The antiproliferative activities of cisplatin and carboplatin (5 µM) were increased in the presence of [(WR)5C]-GdNPs (50 μM) by 41% and 18%, respectively, after 72-h incubation in CCRF-CEM cells. The intracellular release of epirubicin, an anticancer drug, from the complex showed that 15% and 60% of the drug was released intracellularly within 12 and 48 h, respectively. This report provides insight about using a non-toxic MRI agent, gadolinium nanoparticles, for the delivery of various types of molecular cargos." @default.
- W3081215975 created "2020-09-01" @default.
- W3081215975 creator A5002648365 @default.
- W3081215975 creator A5008412708 @default.
- W3081215975 creator A5009711770 @default.
- W3081215975 creator A5016314740 @default.
- W3081215975 creator A5031842435 @default.
- W3081215975 creator A5033339559 @default.
- W3081215975 creator A5035830609 @default.
- W3081215975 creator A5044903753 @default.
- W3081215975 creator A5052833222 @default.
- W3081215975 creator A5059669763 @default.
- W3081215975 creator A5090883774 @default.
- W3081215975 date "2020-08-21" @default.
- W3081215975 modified "2023-10-16" @default.
- W3081215975 title "Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery" @default.
- W3081215975 cites W1594148627 @default.
- W3081215975 cites W1805299795 @default.
- W3081215975 cites W1974933012 @default.
- W3081215975 cites W1980256832 @default.
- W3081215975 cites W1985105201 @default.
- W3081215975 cites W1987639962 @default.
- W3081215975 cites W2003627965 @default.
- W3081215975 cites W2005192539 @default.
- W3081215975 cites W2019872824 @default.
- W3081215975 cites W2022891152 @default.
- W3081215975 cites W2026271132 @default.
- W3081215975 cites W2063421454 @default.
- W3081215975 cites W2079855031 @default.
- W3081215975 cites W2098164853 @default.
- W3081215975 cites W2166618356 @default.
- W3081215975 cites W2167806590 @default.
- W3081215975 cites W2189902401 @default.
- W3081215975 cites W2270085459 @default.
- W3081215975 cites W2325115141 @default.
- W3081215975 cites W2333340386 @default.
- W3081215975 cites W2334523147 @default.
- W3081215975 cites W2335878664 @default.
- W3081215975 cites W2413230412 @default.
- W3081215975 cites W2516983065 @default.
- W3081215975 cites W2530202933 @default.
- W3081215975 cites W2560178729 @default.
- W3081215975 cites W2586518869 @default.
- W3081215975 cites W2607439181 @default.
- W3081215975 cites W2618333020 @default.
- W3081215975 cites W2626613451 @default.
- W3081215975 cites W2810118435 @default.
- W3081215975 cites W2963206469 @default.
- W3081215975 cites W2967598312 @default.
- W3081215975 cites W3004225782 @default.
- W3081215975 cites W4376634231 @default.
- W3081215975 doi "https://doi.org/10.3390/pharmaceutics12090792" @default.
- W3081215975 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7557599" @default.
- W3081215975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32825689" @default.
- W3081215975 hasPublicationYear "2020" @default.
- W3081215975 type Work @default.
- W3081215975 sameAs 3081215975 @default.
- W3081215975 citedByCount "4" @default.
- W3081215975 countsByYear W30812159752021 @default.
- W3081215975 countsByYear W30812159752022 @default.
- W3081215975 countsByYear W30812159752023 @default.
- W3081215975 crossrefType "journal-article" @default.
- W3081215975 hasAuthorship W3081215975A5002648365 @default.
- W3081215975 hasAuthorship W3081215975A5008412708 @default.
- W3081215975 hasAuthorship W3081215975A5009711770 @default.
- W3081215975 hasAuthorship W3081215975A5016314740 @default.
- W3081215975 hasAuthorship W3081215975A5031842435 @default.
- W3081215975 hasAuthorship W3081215975A5033339559 @default.
- W3081215975 hasAuthorship W3081215975A5035830609 @default.
- W3081215975 hasAuthorship W3081215975A5044903753 @default.
- W3081215975 hasAuthorship W3081215975A5052833222 @default.
- W3081215975 hasAuthorship W3081215975A5059669763 @default.
- W3081215975 hasAuthorship W3081215975A5090883774 @default.
- W3081215975 hasBestOaLocation W30812159751 @default.
- W3081215975 hasConcept C12554922 @default.
- W3081215975 hasConcept C155672457 @default.
- W3081215975 hasConcept C171250308 @default.
- W3081215975 hasConcept C178790620 @default.
- W3081215975 hasConcept C181199279 @default.
- W3081215975 hasConcept C185592680 @default.
- W3081215975 hasConcept C192562407 @default.
- W3081215975 hasConcept C2779201268 @default.
- W3081215975 hasConcept C2779281246 @default.
- W3081215975 hasConcept C2779820397 @default.
- W3081215975 hasConcept C55493867 @default.
- W3081215975 hasConcept C557651011 @default.
- W3081215975 hasConcept C60984968 @default.
- W3081215975 hasConcept C79879829 @default.
- W3081215975 hasConcept C86803240 @default.
- W3081215975 hasConceptScore W3081215975C12554922 @default.
- W3081215975 hasConceptScore W3081215975C155672457 @default.
- W3081215975 hasConceptScore W3081215975C171250308 @default.
- W3081215975 hasConceptScore W3081215975C178790620 @default.
- W3081215975 hasConceptScore W3081215975C181199279 @default.
- W3081215975 hasConceptScore W3081215975C185592680 @default.
- W3081215975 hasConceptScore W3081215975C192562407 @default.
- W3081215975 hasConceptScore W3081215975C2779201268 @default.
- W3081215975 hasConceptScore W3081215975C2779281246 @default.